Monosaccaridi

Intermediate in the synthesis of Decitabine

1,3,4,6-Tetra-O-acetyl-2-azido-2-deoxy-b-D-galactopyranose (TAZ) is an aromatic heterocyclic sugar compound that is used in pharmaceutical formulations. It has low toxicity and can be synthesized using a number of methods. TAZ has been shown to have antifungal effects against Candida albicans and antitumor effects against cancer cells. TAZ also inhibits the activity of teniposide, which is a drug used for the treatment of leukemia. TAZ may be effective against cancer cells by acting as an amido donor and changing the conformation of the cyclic peptide.

Methyl 2,3,4,6-tetra-O-benzyl-b-D-thiogalactopyranoside is a synthetic monosaccharide that has been modified with fluorination and glycosylation. It is a product of the click reaction, which is a chemical modification that involves the formation of an aziridine and an alkene in one step. This product has been used for the synthesis of oligosaccharides and complex carbohydrates.

Used for preparation of biologically active compounds

D-Talitol is a drug that is used to treat eye disorders and chronic pulmonary diseases. It belongs to the class of drugs called xylitol dehydrogenase inhibitors. D-Talitol inhibits the enzyme xylitol dehydrogenase, which converts xylitol into a different sugar called sorbitol. Sorbitol accumulates in certain parts of cells, such as the mitochondria, and can disrupt cellular processes by inhibiting oxidative phosphorylation and glycolysis. In addition, there are other effects of sorbitol accumulation that may lead to mitochondrial dysfunction, including inhibition of protein synthesis, induction of apoptosis (cell death), and inhibition of cell proliferation. D-Talitol has been shown to inhibit the growth of chronic kidney cells in culture by interfering with cellular metabolism in mitochondria. A kinetic study has also shown that D-Talitol inhibits b-raf activity at concentrations that are not cytotoxic. This suggests that D-Talitol may be useful for

a-Homonojirimycin is a chaperone that is effective in inhibiting HIV infection. It has been shown to inhibit the activity of chymotrypsin, carboxypeptidase A, and aminopeptidase B. The model system used for this compound was the human liver, which showed that a-homonojirimycin had a potent inhibitory activity against these enzymes. This drug also has a dry weight of 1,520 g/mol and an effective dose of 0.01 mg/mL. In vitro studies have shown that a-homonojirimycin inhibits influenza virus by binding to the hemagglutinin protein on the surface of the virus and preventing its attachment to host cells.

1,2,3,4,6-Penta-O-pivaloyl-a-D-glucopyranoside is a synthetic carbohydrate that has been fluorinated and methylated. This product is a modification of the natural compound D-glucose. It is an oligosaccharide which contains six pivaloyl groups attached to the 1-, 2-, 3-, 4-, 6-, and 7-positions on the glucose molecule. This product can be used in the synthesis of polysaccharides and glycosylations.

1,2,3,5-Tetra-O-acetyl-D-xylofuranose is a lectin that has been shown to have an affinity for bacterial cells. It has been shown to be effective against Gram-positive and Gram-negative bacteria, with the exception of mycobacteria. 1,2,3,5-Tetra-O-acetyl-D-xylofuranose binds to the terminal sugar of the cell wall carbohydrate chains of these cells by means of its oligosaccharide side chain. The binding causes conformational changes in the bacterial membrane and disrupts the ion gradient across it. This leads to an influx of water into the cell and subsequent death.

Superdisintegrant used in pharmaceutical formulations

Methyl a-L-acosamine is a glycosylation agent that can be used to modify complex carbohydrates. It can also be used in the methylation of saccharides, polysaccharides, and sugars. Methyl a-L-acosamine is made by reacting acetic anhydride with L-a-D-galactopyranosyl chloride. The CAS number for this product is 54623-23-3. This product can be custom synthesized to meet your specifications and has high purity.

Synthetic carbohydrate building block

Glucose analog and potent inhibitor of α-glucosidases of class I and II. It interferes with N-linked glycosylation and oligosaccharide processing. The compound inhibits intestinal α-glucosidase and has protective effects against obesity-induced hepatic injury as well as mitochondrial dysfunction. It also has neuroprotective effects since it reduces senescence-related cognitive impairment, neuroinflammation and amyloid beta deposition in mice.

L-Lyxono-1,4-lactone is a dehydrogenase that synthesizes hydroxamic acids from aldonic acids. Hydroxamic acids are used as herbicides and insecticides. L-Lyxono-1,4-lactone has been shown to be active against ochrobactrum and branched-chain bacteria. The enzyme catalyzes the cleavage of an aldonic acid to form an alcohol and an alpha,beta unsaturated ketone. This reaction is stereoselective, with the product being the same chiral center in both cases. The enzyme also shows chemometric properties by being able to measure salinity levels in water samples.

Calcium lactate gluconate is an antacid and a calcium supplement. It is a salt of calcium with lactic acid, which is often used to treat or prevent kidney stones and periodontal disease. Calcium lactate gluconate also helps to form new bone by stimulating osteoblasts, the cells responsible for bone formation. This drug can be used therapeutically to increase bone growth in people with osteoporosis or to repair bones after injury. It also helps heal fractures, relieves pain from arthritis, and treats cancer by preventing cell proliferation. Calcium lactate gluconate is a white powder that dissolves in water and can be mixed with other liquids such as fruit juice or milk.

Benzyl 3-O-benzyl-4,6-O-benzylidene-2-deoxy-2-N-phthalamido-a-D-glucopyranoside is a sugar that is used as a building block for the synthesis of glycosaminoglycans. This sugar can be fluorinated, glycosylated, or methylated and is a synthetically modified oligosaccharide with an average molecular weight of about 880 Da. The monomer unit consists of two glucose residues linked by an α(1→4) glycosidic bond. It has been shown to have antihypertensive properties in vitro and in vivo.

Methyl-2,3,4-tri-O-benzoyl-6-bromo-6-deoxy-alpha-D-glucopyranoside is a sugar that belongs to the group of monosaccharides. It is a custom synthesis product that can be synthesized and modified according to customer's requirements. Methylation, fluorination and saccharide modification are possible and highly pure methylated products can be produced with high purity.

1,2,6-Tri-O-acetyl-3,4-di-O-benzyl-a-D-mannopyranose is a synthetic sugar that has been modified with three acetates and benzyl groups. It is used in the synthesis of glycosides and oligosaccharides. 1,2,6-Tri-O-acetyl-3,4-di-O-benzyl-a-D-mannopyranose is also an important building block for the synthesis of complex carbohydrates.

Glyceraldehyde 3-phosphate (G3P) is an intermediate in the glycolytic pathway. It is also a component of polysaccharides and glycosaminoglycans. G3P is synthesized from glucose by the enzyme triose phosphate isomerase. The synthesis of G3P can be achieved by a number of methods, including methylation, fluorination, and click chemistry. This product contains 45-55 mg/mL of Glyceraldehyde 3-phosphate in water solution at pH 7.0 and at a temperature range of 2-8°C.